Honasa Consumer Limited (HONASA) acquires 58% in Fluence Pharma, entering nutraceuticals with patented Cyclical Nutrition Therapy.
Honasa Consumer Limited (HONASA) reports 28% YoY growth in Q4 FY26, doubling EBITDA and PAT, marking third consecutive quarter of 20%+ growth.
